All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @hollymarieshorty on TikTok · 37s|Watch on TikTok

Gastric sleeve surgery: what TikTok gets right and wrong

Mumma with Tourettes 🤰🏼🤍

TikTok creator

69.3K viewsWatch on TikTok

Quick answer

This video documents a post-VSG (vertical sleeve gastrectomy) patient expressing satisfaction with her surgical outcome and anticipating body contouring surgery to address excess skin, a common sequela after significant bariatric weight loss. No GLP-1 content, dosing information, or clinical claims are made in the transcript or caption. The content is personal testimony, not medical guidance, and should be evaluated as such rather than as a clinical recommendation.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Gastric sleeve surgery: what TikTok gets right and wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Gastric sleeve surgery: what TikTok gets right and wrong is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Gastric sleeve surgery: what TikTok gets right and wrong" from Mumma with Tourettes 🤰🏼🤍. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: This video documents a post-VSG (vertical sleeve gastrectomy) patient expressing satisfaction with her surgical outcome and anticipating body contouring surgery to address excess skin, a common sequela after significant bariatric weight loss.

The reason this review is not generic is the source wording and the canonical claim label "glp1 my only regret is i didnt do it sooner bring on skin removal." In this clip, the useful excerpt is: "My only regret is i didnt do it sooner!" That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Approximately 13 to 20 percent of bariatric surgery patients report regret or ambivalence at longer follow-up intervals, per Wee et al.
People who land here are usually comparing the GLP-1 social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' GLP-1 social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

This video documents a post-VSG (vertical sleeve gastrectomy) patient expressing satisfaction with her surgical outcome and anticipating body contouring surgery to address excess skin, a common sequela after significant bariatric weight loss.

FormBlends verdict

GLP-1 social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • This video documents a post-VSG (vertical sleeve gastrectomy) patient expressing satisfaction with her surgical outcome and anticipating body contouring surgery to address excess skin, a common sequela after significant bariatric weight loss. No GLP-1 content, dosing information, or clinical claims are made in the transcript or caption. The content is personal testimony, not medical guidance, and should be evaluated as such rather than as a clinical recommendation.
  • VSG produces average excess weight loss of 50 to 70 percent at two years, per ASMBS position statements, making it one of the more effective surgical interventions available.
  • Approximately 13 to 20 percent of bariatric surgery patients report regret or ambivalence at longer follow-up intervals, per Wee et al. (2019, JAMA Surgery), meaning "no regrets" is the majority experience but not universal.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • VSG produces average excess weight loss of 50 to 70 percent at two years, per ASMBS position statements, making it one of the more effective surgical interventions available.
  • Approximately 13 to 20 percent of bariatric surgery patients report regret or ambivalence at longer follow-up intervals, per Wee et al. (2019, JAMA Surgery), meaning "no regrets" is the majority experience but not universal.
  • Excess skin after major weight loss is reported by the majority of post-bariatric patients as a quality-of-life concern, per Staalesen et al. (2010, Plastic and Reconstructive Surgery), and body contouring surgery is frequently a separate, often out-of-pocket cost.
  • GLP-1 medications like semaglutide produce average total body weight loss of approximately 15 percent at 68 weeks (Wilding et al., 2021, NEJM), a meaningfully different outcome profile than bariatric surgery.
  • The 30-day mortality rate for sleeve gastrectomy is approximately 0.1 to 0.3 percent per MBSAQIP 2020 data, which is low but not zero, and longer-term complication risks including GERD worsening deserve informed consent.
  • This video contains no GLP-1 content despite its platform categorization. It is a VSG patient journey post, and the two treatment categories have different indications, risks, and candidate criteria.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @hollymarieshorty actually say?

Honestly? Not much, medically speaking. The transcript here is a song lyric: "Brothers, there you hold me close, don't let me go." The actual medical messaging lives entirely in the caption, where she writes that her "only regret is I didn't do it sooner" about what she describes as a path toward skin removal surgery following what appears to be significant bariatric-related weight loss. She's documenting a post-VSG (vertical sleeve gastrectomy) journey, not making clinical claims. The emotional framing, the triumph, the nudge toward her separate weight loss account, this is personal testimony content, not medical advice. That context matters for how we evaluate it.

The caption hashtags confirm this is a VSG and bariatric surgery journey. There are no explicit GLP-1 claims made, no dosing suggestions, no disease cure statements. What we have is an emotionally resonant post-surgical success story, and those come with their own set of things worth examining.

Does the science back this up?

The broad sentiment, that people who have bariatric surgery often wish they had done it earlier, is actually supported by patient-reported outcome data. That said, "no regrets" narratives are complicated by survivorship bias and the selective nature of what gets posted publicly.

A 2021 systematic review by Coulman et al. in Obesity Surgery found that the majority of bariatric patients reported satisfaction with their surgery at five-year follow-up, but satisfaction rates did decline over time, particularly in patients who experienced weight regain or complications. A 2019 study by Wee et al. in JAMA Surgery found that while most patients reported improved quality of life post-bariatric surgery, a meaningful subset, roughly 13 to 20 percent depending on the cohort, reported regret or ambivalence at longer follow-up intervals. So "no regrets" is statistically the majority experience, but it is far from universal.

Skin removal surgery, technically called body contouring or panniculectomy, is a real downstream consideration after major weight loss. Research by Staalesen et al. (2010, Plastic and Reconstructive Surgery) confirmed that excess skin is one of the most commonly reported quality-of-life complaints after bariatric-related weight loss, affecting physical comfort, hygiene, and psychological well-being.

What did they get wrong (or right)?

She didn't get anything clinically wrong because she didn't make clinical claims. Credit where it's due: this is a personal journey post, not a medical tutorial. The emotional framing is honest about where she is, post-surgery and anticipating another procedure.

Where there's a gap, and it's worth naming, is what this type of content leaves out for viewers who might be considering VSG themselves. Bariatric surgery carries real risks. The 30-day mortality rate for sleeve gastrectomy is low, approximately 0.1 to 0.3 percent according to the MBSAQIP 2020 data, but long-term complications include GERD worsening, nutritional deficiencies, and yes, weight regain in a portion of patients. The "I wish I did it sooner" framing, while genuine to her experience, presents the best-case emotional arc without the full statistical picture. That's not a lie. It's just incomplete in ways that matter to people making decisions.

Also worth noting: the video is categorized under GLP-1, but there is no GLP-1 content here. This is a VSG story.

What should you actually know?

If you're watching this video and thinking about bariatric surgery or GLP-1 medications as alternatives, here's the honest landscape of evidence. VSG produces average excess weight loss of 50 to 70 percent at two years, per the ASMBS position statement. GLP-1 receptor agonists like semaglutide (Wegovy) produce average total body weight loss of around 15 percent at 68 weeks based on the STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine), with tirzepatide showing up to 20 to 22 percent in the SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM). These are different tools with different risk profiles, different candidate criteria, and different long-term maintenance requirements.

Skin removal surgery after major weight loss is common and often not covered by insurance unless there is a documented functional impairment. It's a real surgical step that requires separate evaluation. If you're early in your weight loss journey, talking to a bariatric surgeon and an obesity medicine specialist together gives you a broader picture than any single TikTok, including this one.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Mumma with Tourettes 🤰🏼🤍 · TikTok creator

69.3K views on this video

My only regret is i didnt do it sooner! Bring on skin removal surgery! Show some love to my weightloss acc @Milf in the making🏋🏼‍♀️ 🫶🏻🥳 #vsg #wls #weightloss #gastricsleeve #gastricsleevesurgery #weightlosssurgery #bariatricsurgery

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about vsg produces average excess weight loss of 50 to 70?

VSG produces average excess weight loss of 50 to 70 percent at two years, per ASMBS position statements, making it one of the more effective surgical interventions available.

What does the video say about approximately 13 to 20 percent of bariatric surgery patients report?

Approximately 13 to 20 percent of bariatric surgery patients report regret or ambivalence at longer follow-up intervals, per Wee et al. (2019, JAMA Surgery), meaning "no regrets" is the majority experience but not universal.

What does the video say about excess skin after major weight loss?

Excess skin after major weight loss is reported by the majority of post-bariatric patients as a quality-of-life concern, per Staalesen et al. (2010, Plastic and Reconstructive Surgery), and body contouring surgery is frequently a separate, often out-of-pocket cost.

What does the video say about glp-1 medications like semaglutide produce average total body weight loss?

GLP-1 medications like semaglutide produce average total body weight loss of approximately 15 percent at 68 weeks (Wilding et al., 2021, NEJM), a meaningfully different outcome profile than bariatric surgery.

What does the video say about the 30-day mortality rate for sleeve gastrectomy?

The 30-day mortality rate for sleeve gastrectomy is approximately 0.1 to 0.3 percent per MBSAQIP 2020 data, which is low but not zero, and longer-term complication risks including GERD worsening deserve informed consent.

What does the video say about this video contains no glp-1 content despite its platform categorization.?

This video contains no GLP-1 content despite its platform categorization. It is a VSG patient journey post, and the two treatment categories have different indications, risks, and candidate criteria.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Mumma with Tourettes 🤰🏼🤍, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.